Patent Issued for Anti-Blys Antibody Formulations And Methods Of Treatment Using Them (USPTO 10,556,009)

Source :: Cardiovascular Week. February 24, 2020, 727
Publication Year :: 2020
Abstract: 2020 FEB 24 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- GlaxoSmithKline Intellectual Property (Brentford, Middlesex, United Kingdom) has been issued patent number 10,556,009, according to [...]

Subjects :: Patient compliance -- Methods
Amino acids -- Intellectual property -- Methods
Antibodies -- Methods
Biological products -- Intellectual property -- Methods
Editors
Health

Tools